The expanding demand for controlled immunological investigation and therapeutic design has spurred significant improvements in recombinant cytokine production. IL-1A, IL-1B, IL-2, and IL-3, each possessing unique functional roles, are frequently generated using diverse expression platforms, including bacterial hosts, animal cell lines, and baculovi